Mylan Announces Settlement Agreement in Litigation Relating to Detrol® LA
03:37 EDT 7 Sep 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
PITTSBURGH, Sept. 7, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB th...
Other Sources for this Article
More From BioPortfolio on "Mylan Announces Settlement Agreement in Litigation Relating to Detrol® LA"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
